Complications of switching from anti-IL-5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma

J Allergy Clin Immunol Pract. 2021 Jul;9(7):2913-2915. doi: 10.1016/j.jaip.2021.02.042. Epub 2021 Mar 4.

Authors

Katrien Eger¹, Lodewijk Pet², Els J M Weersink², Elisabeth H Bel²

Affiliations

¹ Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: k.a.eger@amsterdamumc.nl.
² Department of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

PMID: 33676050
DOI: 10.1016/j.jaip.2021.02.042

No abstract available

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Antibodies, Monoclonal, Humanized*
Asthma* / drug therapy
Humans

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
dupilumab